ELI LILLY & Co is 332.9x more valuable than Telix Pharmaceuticals Ltd by market capitalization ($1.070 T vs $3.21 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TLX | LLY |
|---|---|---|
| Market cap | $3.21 B | $1.070 T |
| US-listed rank | #1754 | #10 |
| Revenue (latest FY) | - | $65.18B |
| Net income (latest FY) | - | $20.64B |
| Net margin | - | 31.7% |
| P/E (trailing FY) | - | 51.8 |
| SEC filings | 95 | 989 |
ELI LILLY & Co is 332.9x more valuable than Telix Pharmaceuticals Ltd by market capitalization ($1.070 T vs $3.21 B).
Full pages: Telix Pharmaceuticals Ltd and ELI LILLY & Co, or browse the full rankings.